JAZZ logo

Jazz Pharmaceuticals plc (JAZZ) Cash from investing

annual CFI:

-$508.19M-$345.13M(-211.66%)
December 31, 2024

Summary

  • As of today (September 1, 2025), JAZZ annual cash flow from investing activities is -$508.19 million, with the most recent change of -$345.13 million (-211.66%) on December 31, 2024.
  • During the last 3 years, JAZZ annual CFI has risen by +$4.70 billion (+90.25%).
  • JAZZ annual CFI is now -9622.11% below its all-time high of $5.34 million, reached on December 31, 2007.

Performance

1-year change

-211.66%

3-year change

+90.25%

5-year change

-227.23%

15-year change

-88.96%

JAZZ Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

6.16%
JAZZ annual cash flow from investing activities is higher than 6.16% of companies in Healthcare sector

Range

All-time high

$5.34M
JAZZ annual cash flow from investing activities is currently -9622.11% below its historical high of $5.34 million

3-year low

-$5.21B

Earnings dates

Last annual earnings report date

Dec 31, 2024
JAZZ previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
JAZZ next annual earnings announcement has not yet been scheduled

OtherJAZZcash flow metrics

annual CFF

$20.52M
JAZZ annual cash flow from financing activities is $20.52 million

annual CFO

$1.40B
JAZZ annual cash flow from operations is $1.40 billion

annual FCF

$1.36B
JAZZ annual free cash flow is $1.36 billion

annual CAPEX

$38.07M
JAZZ annual capital expenditures is $38.07 million

quarterly CFI:

-$641.02M-$472.09M(-279.46%)
June 30, 2025

Summary

  • As of today (September 1, 2025), JAZZ quarterly cash flow from investing activities is -$641.02 million, with the most recent change of -$472.09 million (-279.46%) on June 30, 2025.
  • Over the past year, JAZZ quarterly CFI has dropped by -$383.93 million (-149.34%).
  • JAZZ quarterly CFI is now -186.96% below its all-time high of $737.13 million, reached on March 31, 2021.

Performance

3-month change

-279.46%

1-year change

-149.34%

3-year change

-618.94%

5-year change

+13.51%

JAZZ quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

2.02%
JAZZ quarterly cash flow from investing activities is higher than 2.02% of companies in Healthcare sector

Range

All-time high

$737.13M
JAZZ quarterly cash flow from investing activities is currently -186.96% below its historical high of $737.13 million

3-year low

-$641.02M
JAZZ quarterly cash flow from investing activities is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
JAZZ previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Nov 5, 2025
JAZZ next earnings announcement is scheduled for Nov 5, 2025

OtherJAZZcash flow metrics

quarterly CFF

-$124.53M
JAZZ quarterly cash flow from financing activities is -$124.53 million

quarterly CFO

$88.86M
JAZZ quarterly cash flow from operations is $88.86 million

quarterly FCF

$75.89M
JAZZ quarterly free cash flow is $75.89 million

quarterly CAPEX

$12.97M
JAZZ quarterly capital expenditures is $12.97 million

TTM CFI:

-$789.15M-$383.93M(-94.75%)
June 30, 2025

Summary

  • As of today (September 1, 2025), JAZZ TTM cash flow from investing activities is -$789.15 million, with the most recent change of -$383.93 million (-94.75%) on June 30, 2025.
  • Over the past year, JAZZ TTM CFI has dropped by -$187.66 million (-31.20%).
  • JAZZ TTM CFI is now -1098.74% below its all-time high of $79.02 million, reached on September 30, 2013.

Performance

3-month change

-94.75%

1-year change

-31.2%

3-year change

-383.08%

5-year change

+29.54%

JAZZ TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

4.05%
JAZZ TTM cash flow from investing activities is higher than 4.05% of companies in Healthcare sector

Range

All-time high

$79.02M
JAZZ TTM cash flow from investing activities is currently -1098.74% below its historical high of $79.02 million

3-year low

-$789.15M
JAZZ TTM cash flow from investing activities is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
JAZZ previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Nov 5, 2025
JAZZ next earnings announcement is scheduled for Nov 5, 2025

OtherJAZZcash flow metrics

TTM CFF

-$699.84M
JAZZ TTM cash flow from financing activities is -$699.84 million

TTM CFO

$1.32B
JAZZ TTM cash flow from operations is $1.32 billion

TTM FCF

$1.24B
JAZZ TTM free cash flow is $1.24 billion

TTM CAPEX

$75.92M
JAZZ TTM capital expenditures is $75.92 million

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

JAZZ Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-211.7%-149.3%-31.2%
3 y3 years+90.3%-618.9%-383.1%
5 y5 years-227.2%+13.5%+29.5%

JAZZ Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-211.7%+90.3%-399.4%at low-498.1%at low
5 y5-year-227.2%+90.3%-187.0%+89.2%-498.1%+86.8%
alltimeall time-9622.1%+90.3%-187.0%+89.2%-1098.7%+86.8%

JAZZ Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$641.02M(+279.5%)
-$789.15M(+94.7%)
Mar 2025
-
-$168.93M(-12.6%)
-$405.22M(-20.3%)
Dec 2024
-$508.19M(+211.7%)
-$193.29M(-190.3%)
-$508.19M(+138.5%)
Sep 2024
-
$214.09M(-183.3%)
-$213.11M(-64.6%)
Jun 2024
-
-$257.09M(-5.4%)
-$601.50M(+39.8%)
Mar 2024
-
-$271.90M(-367.1%)
-$430.14M(+163.8%)
Dec 2023
-$163.06M(-63.5%)
$101.80M(-158.4%)
-$163.06M(-72.3%)
Sep 2023
-
-$174.30M(+103.3%)
-$589.24M(+43.6%)
Jun 2023
-
-$85.74M(+1678.1%)
-$410.34M(-0.8%)
Mar 2023
-
-$4.82M(-98.5%)
-$413.76M(-7.3%)
Dec 2022
-$446.23M(-91.4%)
-$324.38M(-7148.6%)
-$446.23M(+238.2%)
Sep 2022
-
$4.60M(-105.2%)
-$131.94M(-19.2%)
Jun 2022
-
-$89.16M(+139.1%)
-$163.36M(-97.3%)
Mar 2022
-
-$37.29M(+269.5%)
-$5.99B(+14.9%)
Dec 2021
-$5.21B(+417.2%)
-$10.09M(-62.4%)
-$5.21B(+1.6%)
Sep 2021
-
-$26.81M(-99.5%)
-$5.13B(-4.7%)
Jun 2021
-
-$5.91B(-902.1%)
-$5.38B(+2457.1%)
Mar 2021
-
$737.13M(+906.7%)
-$210.46M(-79.1%)
Dec 2020
-$1.01B(+548.9%)
$73.22M(-126.2%)
-$1.01B(-18.7%)
Sep 2020
-
-$279.64M(-62.3%)
-$1.24B(+10.7%)
Jun 2020
-
-$741.16M(+1133.6%)
-$1.12B(+193.6%)
Mar 2020
-
-$60.08M(-62.2%)
-$381.43M(+145.6%)
Dec 2019
-$155.30M(-60.6%)
-$159.05M(-0.4%)
-$155.30M(-514.2%)
Sep 2019
-
-$159.66M(+5952.4%)
$37.49M(+494.2%)
Jun 2019
-
-$2.64M(-101.6%)
$6.31M(-103.5%)
Mar 2019
-
$166.05M(+392.1%)
-$181.29M(-54.0%)
Dec 2018
-$394.49M(+46.7%)
$33.74M(-117.7%)
-$394.49M(-14.3%)
Sep 2018
-
-$190.85M(+0.3%)
-$460.11M(-2.6%)
Jun 2018
-
-$190.23M(+303.5%)
-$472.61M(+51.2%)
Mar 2018
-
-$47.15M(+47.9%)
-$312.52M(+16.2%)
Dec 2017
-$268.95M(-84.6%)
-$31.88M(-84.3%)
-$268.95M(+13.4%)
Sep 2017
-
-$203.35M(+574.4%)
-$237.08M(-84.8%)
Jun 2017
-
-$30.15M(+743.6%)
-$1.56B(-10.1%)
Mar 2017
-
-$3.57M(>+9900.0%)
-$1.74B(-0.5%)
Dec 2016
-$1.75B(>+9900.0%)
-$4000.00(-100.0%)
-$1.75B(-0.2%)
Sep 2016
-
-$1.53B(+642.3%)
-$1.75B(+672.6%)
Jun 2016
-
-$206.27M(+1619.6%)
-$226.86M(+595.6%)
Mar 2016
-
-$11.99M(+248.7%)
-$32.62M(+1301.0%)
DateAnnualQuarterlyTTM
Dec 2015
-$2.33M(-99.8%)
-$3.44M(-33.3%)
-$2.33M(-82.2%)
Sep 2015
-
-$5.16M(-57.1%)
-$13.06M(-85.7%)
Jun 2015
-
-$12.02M(-165.7%)
-$91.04M(-1.2%)
Mar 2015
-
$18.29M(-229.1%)
-$92.15M(-91.4%)
Dec 2014
-$1.07B(+9368.3%)
-$14.17M(-83.0%)
-$1.07B(+1.0%)
Sep 2014
-
-$83.14M(+533.1%)
-$1.06B(+8.3%)
Jun 2014
-
-$13.13M(-98.6%)
-$975.60M(+1.0%)
Mar 2014
-
-$957.20M(>+9900.0%)
-$966.04M(+8467.2%)
Dec 2013
-$11.28M(-97.1%)
-$3.10M(+43.3%)
-$11.28M(-114.3%)
Sep 2013
-
-$2.16M(-39.3%)
$79.02M(+2.0%)
Jun 2013
-
-$3.57M(+46.0%)
$77.43M(-116.1%)
Mar 2013
-
-$2.44M(-102.8%)
-$480.25M(+21.5%)
Dec 2012
-$395.29M(+384.2%)
$87.19M(-2425.7%)
-$395.29M(-27.9%)
Sep 2012
-
-$3.75M(-99.3%)
-$548.48M(-1.8%)
Jun 2012
-
-$561.24M(-780.2%)
-$558.36M(<-9900.0%)
Mar 2012
-
$82.51M(-225.0%)
$2.07M(-102.5%)
Dec 2011
-$81.63M(+3709.2%)
-$66.00M(+384.5%)
-$81.63M(+387.5%)
Sep 2011
-
-$13.62M(+1561.2%)
-$16.75M(+326.1%)
Jun 2011
-
-$820.00K(-31.2%)
-$3.93M(-8.3%)
Mar 2011
-
-$1.19M(+7.0%)
-$4.29M(+100.0%)
Dec 2010
-$2.14M(-65.0%)
-$1.11M(+38.1%)
-$2.14M(-64.7%)
Sep 2010
-
-$806.00K(-31.4%)
-$6.07M(-15.3%)
Jun 2010
-
-$1.18M(-223.6%)
-$7.17M(+13.7%)
Mar 2010
-
$951.00K(-118.9%)
-$6.31M(+3.0%)
Dec 2009
-$6.12M(-48.7%)
-$5.04M(+164.8%)
-$6.12M(-24.2%)
Sep 2009
-
-$1.91M(+510.6%)
-$8.07M(<-9900.0%)
Jun 2009
-
-$312.00K(-127.4%)
$51.00K(-100.6%)
Mar 2009
-
$1.14M(-116.3%)
-$7.88M(-34.0%)
Dec 2008
-$11.94M(-323.8%)
-$6.99M(-212.4%)
-$11.94M(-367.9%)
Sep 2008
-
$6.22M(-175.5%)
$4.46M(-133.7%)
Jun 2008
-
-$8.24M(+181.6%)
-$13.23M(+112.3%)
Mar 2008
-
-$2.93M(-131.1%)
-$6.23M(-216.8%)
Dec 2007
$5.34M(-454.1%)
$9.40M(-182.0%)
$5.34M(-231.2%)
Sep 2007
-
-$11.47M(+823.5%)
-$4.07M(-155.0%)
Jun 2007
-
-$1.24M(-114.4%)
$7.40M(-14.4%)
Mar 2007
-
$8.64M
$8.64M
Dec 2006
-$1.51M(-99.0%)
-
-
Dec 2005
-$153.75M(+2165.1%)
-
-
Dec 2004
-$6.79M
-
-

FAQ

  • What is Jazz Pharmaceuticals plc annual cash flow from investing activities?
  • What is the all time high annual CFI for Jazz Pharmaceuticals plc?
  • What is Jazz Pharmaceuticals plc annual CFI year-on-year change?
  • What is Jazz Pharmaceuticals plc quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Jazz Pharmaceuticals plc?
  • What is Jazz Pharmaceuticals plc quarterly CFI year-on-year change?
  • What is Jazz Pharmaceuticals plc TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Jazz Pharmaceuticals plc?
  • What is Jazz Pharmaceuticals plc TTM CFI year-on-year change?

What is Jazz Pharmaceuticals plc annual cash flow from investing activities?

The current annual CFI of JAZZ is -$508.19M

What is the all time high annual CFI for Jazz Pharmaceuticals plc?

Jazz Pharmaceuticals plc all-time high annual cash flow from investing activities is $5.34M

What is Jazz Pharmaceuticals plc annual CFI year-on-year change?

Over the past year, JAZZ annual cash flow from investing activities has changed by -$345.13M (-211.66%)

What is Jazz Pharmaceuticals plc quarterly cash flow from investing activities?

The current quarterly CFI of JAZZ is -$641.02M

What is the all time high quarterly CFI for Jazz Pharmaceuticals plc?

Jazz Pharmaceuticals plc all-time high quarterly cash flow from investing activities is $737.13M

What is Jazz Pharmaceuticals plc quarterly CFI year-on-year change?

Over the past year, JAZZ quarterly cash flow from investing activities has changed by -$383.93M (-149.34%)

What is Jazz Pharmaceuticals plc TTM cash flow from investing activities?

The current TTM CFI of JAZZ is -$789.15M

What is the all time high TTM CFI for Jazz Pharmaceuticals plc?

Jazz Pharmaceuticals plc all-time high TTM cash flow from investing activities is $79.02M

What is Jazz Pharmaceuticals plc TTM CFI year-on-year change?

Over the past year, JAZZ TTM cash flow from investing activities has changed by -$187.66M (-31.20%)
On this page